Skip to main content
. 2022 Sep 9;607:128173. doi: 10.1016/j.physa.2022.128173

Table 2.

The description of parameters and values.

Parameter Description Value Source
π Recruitment rate of susceptible individuals 1.2×104 [47]
ηA Infection modification parameter for the asymptomatic infection rate 0.45 [48]
ηH Infection modification parameter for the hospitalized infection rate 0.4509 [48]
βc Transmission rate of COVID-19 0.5249 [47]
βf Transmission rate of influenza 0.203 [49]
νc Vaccination rate against COVID-19 0.0203 [45]
νf Vaccination rate against influenza 0.00027375 [50]
νcf Vaccination rate against COVID-19 and influenza 0.00027375–0.0203 Assumed
κc Immunity waning rate of recovered individuals with COVID-19 0.011 [31]
κf Immunity waning rate of recovered individuals with influenza 0.088 [51]
κcf Immunity waning rate of recovered individuals with co-infection 0.011–0.088 Assumed
ωc Vaccine waning rate of COVID-19 0.000297 [47]
ωf Vaccine waning rate of influenza 0.15 [51]
ωcf Vaccine waning rate of COVID-19 and influenza 0.000297–0.15 Assumed
ɛc COVID-19 vaccine efficacy 0.70 [47]
ɛf Influenza vaccine efficacy 0.77 [50]
ɛcf COVID-19 and influenza vaccine efficacy 0.80 Assumed
σc COVID-19 progression rate from the exposed to either 0.40 [47]
asymptomatic or symptomatic infectious
σf Influenza progression rate from the exposed to infectious 0.40 [52]
σcf co-infection progression rate from the exposed to infectious 0.40 Assumed
ψ Fraction of COVID-19 exposed individuals becoming symptomatic 0.60 [53]
μ Natural mortality rate 0.0003516 [47]
δc Death due to COVID-19 0.008 [54]
δf Death due to influenza 0.021 [50]
δcf Death due to co-infection 0.021–0.026 Assumed
τc Hospitalization rate of symptomatic infectious individuals 0.0624 [33]
θc Recovery rate of COVID-19 asymptomatic infectious individuals 0.13978 [33]
γc Recovery rate of COVID-19 hospitalized infectious individuals 0.125 [47]
γf Recovery rate of influenza infectious individuals 0.1998 [50]
γcf Recovery rate of co-infected infectious individuals 0.125–0.1998 Assumed
ϕc Reduction of susceptibility to COVID-19 infection 0.50 Assumed
ϕf Reduction of susceptibility to influenza infection 0.50 Assumed